957
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Febuxostat is superior to traditional urate-lowering agents in reducing the progression of kidney function in chronic kidney disease patients

, , , & | (Reviewing Editor)
Article: 1213215 | Received 21 Jun 2016, Accepted 12 Jul 2016, Published online: 09 Aug 2016

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.